TCIM
RGLS
TIAA CREF Investment Management’s Regulus Therapeutics RGLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-123,293
| Closed | -$203K | – | 3167 |
|
|
2017
Q1 | $203K | Hold |
123,293
| – | – | ﹤0.01% | 2989 |
|
|
2016
Q4 | $277K | Sell |
123,293
-2,135
| -2% | -$4.8K | ﹤0.01% | 2991 |
|
|
2016
Q3 | $414 | Hold |
125,428
| – | – | ﹤0.01% | 2926 |
|
|
2016
Q2 | $362K | Buy |
125,428
+34,352
| +38% | +$99.1K | ﹤0.01% | 2988 |
|
|
2016
Q1 | $631K | Hold |
91,076
| – | – | ﹤0.01% | 2705 |
|
|
2015
Q4 | $794K | Sell |
91,076
-5,430
| -6% | -$47.3K | ﹤0.01% | 2711 |
|
|
2015
Q3 | $631K | Hold |
96,506
| – | – | ﹤0.01% | 2812 |
|
|
2015
Q2 | $1.06M | Buy |
96,506
+47,172
| +96% | +$517K | ﹤0.01% | 2668 |
|
|
2015
Q1 | $836K | Buy |
49,334
+6,725
| +16% | +$114K | ﹤0.01% | 2718 |
|
|
2014
Q4 | $683K | Sell |
42,609
-3,556
| -8% | -$57K | ﹤0.01% | 2852 |
|
|
2014
Q3 | $315K | Sell |
46,165
-1,819
| -4% | -$12.4K | ﹤0.01% | 3055 |
|
|
2014
Q2 | $386K | Buy |
47,984
+8,854
| +23% | +$71.2K | ﹤0.01% | 3050 |
|
|
2014
Q1 | $353K | Hold |
39,130
| – | – | ﹤0.01% | 3024 |
|
|
2013
Q4 | $289K | Hold |
39,130
| – | – | ﹤0.01% | 3058 |
|
|
2013
Q3 | $369K | Buy |
39,130
+3,119
| +9% | +$29.4K | ﹤0.01% | 3002 |
|
|
2013
Q2 | $353K | Buy |
+36,011
| New | +$353K | ﹤0.01% | 3009 |
|